Macular pigment: quantitative analysis on autofluorescence images

  • M. Trieschmann
  • G. Spital
  • A. Lommatzsch
  • E. van Kuijk
  • F. Fitzke
  • A. C. Bird
  • D. Pauleikhoff
Clinical Investigation



Macular pigment (MP) reduces oxidative damage in the central retina and can be quantified by flicker-photometric analysis (HFP) of MP optical density. These analyses demonstrate a very good correlation with central absorption by MP on autofluorescence (AF) images. With these techniques different types of MP-distribution have been described. In the present study a quantification analysis of MP in AF images was developed to verify these MP types and to compare MP distribution patterns between healthy individuals and those with age-related macular degeneration (AMD).


AF images (HRA) were analysed with respect to the area of central and paracentral absorption in 400 eyes with a computerised analysis program of MP optical density. The patients were between 41 and 90 years old (mean 67.2 years); 168 were male and 232 female, and 253 had early AMD and 147 showed no AMD characteristics. The central MP concentrations (peak) were measured, the amount of MP values within the first 8-pixel radius (“C”), the total amount of MP within a 120-pixel radius (“T”) were calculated as the volume of the MP values over the regarded radius and the C/T ratio was registered.


Four types of MP distribution (type 1, intense central and paracentral MP; type 2, less intense central and paracentral MP; type 3, only central MP; type 4, only paracentral MP) were identified. The differences in MP distribution were confirmed and clearly characterised by quantitative analyses of peak, total MP (“T”), central MP (“C”) and C/T ratio: mean peak in type 1, 0.65; type 2, 0.42; type 3, 0.42; type 4, 0.29; mean total amount of MP in 120-pixel radius (“T”) in type 1, 5829.0; type 2, 4412.5; type 3, 2709; type 4, 4302.8. MP types with lower levels of MP were significantly more often observed in the AMD group (AMD: type 1, 120=47.4%; types 2–4, 133=52.6%; healthy eyes: type 1, 112=76.2%; types 2–4, 35=23.8%) (P<0.0001)


Analysis of MP on AF images is a quantitative method for investigation of MP. With this method a wide variation in concentration and distribution of MP could be seen in the population. Four different types of MP distribution could be characterised and quantitatively distinguished. Reduced levels of MP seem to be associated with a higher risk of development of AMD as they were significantly more often observed in the AMD group. This strategy of quantitative MP analysis on AF images is easily practicable and may be used in further studies to investigate the role of MP as a potential risk factor for AMD.


Lutein Zeaxanthin Macular Pigment Macular Pigment Optical Density Optical Density Curve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age related macular degeneration. Br J Ophthalmol 83:867–877PubMedGoogle Scholar
  2. 2.
    Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134CrossRefPubMedGoogle Scholar
  3. 3.
    Beatty S, Koh HH, Carden D, Murray IJ ( 2000) Macular pigment optical density measurement:a novel compact instrument . Ophthalmic Physiol Opt 20:105–111PubMedGoogle Scholar
  4. 4.
    Beatty S, Murray IJ, Henson DB, Carden D, Koh HH, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a northern European population. Invest Ophthalmol Vis Sci 42:439–446PubMedGoogle Scholar
  5. 5.
    Berendschot TT, Willemse-Assink JJ,Bastiaanse M, de Jong PT, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928–1932PubMedGoogle Scholar
  6. 6.
    Berendschott TJ, van de Kraats J, van Norren D (2001) Wavelength dependence of the Stiles–Crawford effect explained by perception of backscattered light from the choroids.J Opt Soc Am A Opt Image Sci Vis 18:1445–51PubMedGoogle Scholar
  7. 7.
    Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R, et al (1995) An international classification and grading system for age related maculopathy in age-related macular degeneration. Surv Ophthalmol 39:367–374PubMedGoogle Scholar
  8. 8.
    Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular pigment. Vision Res 25:1531–1535CrossRefPubMedGoogle Scholar
  9. 9.
    Bone RA, Landrum JT, Fernandez L (1988) Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 29:843–849PubMedGoogle Scholar
  10. 10.
    Bone RA, Landrum JT, Friedes LM (1997) Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 64:211–218CrossRefPubMedGoogle Scholar
  11. 11.
    Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD. A case-control study. Invest Ophthalmol Vis Sci 42:235–240PubMedGoogle Scholar
  12. 12.
    Ciulla TA,Curran-Celentano J, Cooper DA et al (2001) Macular pigment optical density in a midwestern sample. Ophthalmology 108:350–355CrossRefGoogle Scholar
  13. 13.
    Curcio CA, Medeiros NE, Millican CL (1998) The Alabama Age-related Macular Degeneration Grading system for donor eyes Invest Ophthalmol Vis Sci 39:1085–1096Google Scholar
  14. 14.
    Delori FC, Goger DG, Hammond BR, Snodderley DM, Burns SA (2001) Macular pigment density measured by AF spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A 18:1212–1230Google Scholar
  15. 15.
    Eye Disease Case-Control Study Group (1993) Arch Ophthalmol 111:104–109PubMedGoogle Scholar
  16. 16.
    Hammond BR, Caruso-Avery M (2000) Macular pigment optical density in a southwestern sample. Invest Ophthalmol Vis Sci 41:1492–1497PubMedGoogle Scholar
  17. 17.
    Hammond BR, Fuld K (1992) Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci 33:350–355PubMedGoogle Scholar
  18. 18.
    Hammond BR, Fuld K, Snodderly DM (1996) Iris colour and macular pigment optical density. Exp Eye Res 62:715–720Google Scholar
  19. 19.
    Hammond BR, Johnson EJ, Russell RM et al (1997) Dietary modification of human macular density. Invest Ophthalmol Vis Sci 38:1795–1801PubMedGoogle Scholar
  20. 20.
    Kirschfield K (1982) Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc R Soc Lond B 216:71–85PubMedGoogle Scholar
  21. 21.
    Klein R, Davis MD, Magli YL, Segal P,Klein BEK, Hubbard L (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98:1128–1134Google Scholar
  22. 22.
    Landrum JT, Bone RA, Vidal I, Menendez E, Kilburn M (1995) Macular pigment stereomers in individual eyes: a comparison between normals and those with age-related macular degeneration. Invest Ophthalmol Vis Sci 36 [Suppl]: 857–863Google Scholar
  23. 23.
    Landrum JT,Bone RA,Kilburn MD (1997) The macular pigment—a possible role in protection from age related macular degeneration. Adv Pharmacol 38:537–556PubMedGoogle Scholar
  24. 24.
    Leung I, Tso M, Li W, Lam T (2001) Absorption and tissue distribution of zeaxanthin and lutein in rhesus monkeys after taking Fructus lycii (Gou Qi Zi) extract. Invest Ophthalmol Vis Sci 42:466–471PubMedGoogle Scholar
  25. 25.
    Lois N, Halfyard AS, Bird AC, Fitzke FW (2000) Quantitative evaluation of fundus autofluorescence imaged “in vivo” in eyes with retinal disease. Br J Ophthalmol 84:741–745CrossRefPubMedGoogle Scholar
  26. 26.
    Moreland JD, Bhatt P (1984) Retinal distribution of retinal pigment. Doc Ophthalmol Proc Ser 39:127–132Google Scholar
  27. 27.
    Moreland JD, Robson AG, Soto-Leon N, Kulikowski JJ (1998) Macular pigment and the colour-specificity of visual evoked potentials. Vision Res 38:3241–3245CrossRefPubMedGoogle Scholar
  28. 28.
    Nussbaum JJ, Pruett RC, Delori FC (1981) Macular yellow pigment. The first 200 years. Retina 1:296–310PubMedGoogle Scholar
  29. 29.
    Pauleikhoff D, van Kuijk FJGM, Alexander R, Luthert P, Bird AC (2002) Histological evaluation of localization and distribution of macular pigment in the human retina. Invest Ophthalmol Vis Sci [Suppl] S102Google Scholar
  30. 30.
    Pease PL, Adams AJ, Nuccio E (1987) Optical density of human macular pigment. Vision Res 27:705–710CrossRefPubMedGoogle Scholar
  31. 31.
    Rapp LM, Maple SS, Choi JH (2000 ) Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina.Invest Ophthalmol Vis Sci 41:1200–1209Google Scholar
  32. 32.
    Robson AG, Moreland JD, Pauleikhoff D, Morrissey T, Holder GE, Fitzke FW, C Bird A, van Kuijk FJ (2002) Macular pigment density and distribution: comparison of the fundus autofluorescence with minimum motion photometry. Vision Res 43:1765–75CrossRefGoogle Scholar
  33. 33.
    Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett W (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. J Am Med Assoc 272:1413–1420CrossRefGoogle Scholar
  34. 34.
    Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotinoids and antioxidant vitamins. Am J Clin Nutr 62:1448–1461Google Scholar
  35. 35.
    Snodderly DM, Brown PK, Auran JD, Delori FC (1984) The macular pigment. I. Absorbance spectra, localisation and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673PubMedGoogle Scholar
  36. 36.
    Snodderly DM, Handelmann GJ, Adler AJ (1991) Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 32:268–279PubMedGoogle Scholar
  37. 37.
    Sommerburg O, Siems WG,Hurst JS, Lewis JW, Kliger DS, van Kuijk FGJM (1999) Lutein and Zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res 19:491–495CrossRefPubMedGoogle Scholar
  38. 38.
    van Kuijk FJGM, Pelosini L, Patel J, Pauleikhoff D, Fitzke F, Bird AC:Grading of macular pigment phenotypes using autofluorescence imaging Invest Ophthalmol Vis Sci [Suppl] S102Google Scholar
  39. 39.
    Vienot F (1997) Effect of macular pigmentation and cone effective optical density on colour matches. XIVth Symposium IRGCVD, P25Google Scholar
  40. 40.
    Von Rückmann A, Fitzke FW, Bird AC (1995) Distribution of funds auto fluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol 79:407–412PubMedGoogle Scholar
  41. 41.
    Von Rückmann A, Fitzke FW, Bird AC (1997) Fundus autofluorescence in age-related macular disease with a scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci 38:478–486PubMedGoogle Scholar
  42. 42.
    Von Rückmann A, Fitzke FW, Bird AC (1999) Distribution of pigment epithelium auto fluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol, 237:1-9Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • M. Trieschmann
    • 1
  • G. Spital
    • 1
  • A. Lommatzsch
    • 1
  • E. van Kuijk
    • 2
  • F. Fitzke
    • 3
  • A. C. Bird
    • 4
  • D. Pauleikhoff
    • 1
  1. 1.Department of OphthalmologySt. Franziskus HospitalMünsterGermany
  2. 2.University of Texas Medical BranchGalvestonUSA
  3. 3.Department of Visual ScienceInstitute of OphthalmologyLondonUK
  4. 4.Moorfields Eye HospitalLondonUK

Personalised recommendations